{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:07:00Z","timestamp":1790363220961,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","award":["2018-408"],"award-info":[{"award-number":["2018-408"]}],"id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010120","name":"Huashan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jgar.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T13:48:35Z","timestamp":1654868915000},"page":"123-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria"],"prefix":"10.1016","volume":"30","author":[{"given":"Xun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siquan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.jgar.2022.06.003_bib0001","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0924-8579(07)72176-3","article-title":"Non-fermentative Gram-negative bacteria","volume":"29","author":"Enoch","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.06.003_bib0002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/11207380-000000000-00000","article-title":"Sitafloxacin: in bacterial infections","volume":"71","author":"Keating","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2022.06.003_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jmii.2014.02.002","article-title":"Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex","volume":"48","author":"Huang","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2022.06.003_bib0004","first-page":"469","article-title":"In vitro activity of sitafloxacin and other antibiotics against bacterial isolates from HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University and Samitivej Sukhumvit Hospital","volume":"100","author":"Tantisiriwat","year":"2017","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jgar.2022.06.003_bib0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10096-021-04278-3","article-title":"Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China","volume":"40","author":"Wu","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2022.06.003_bib0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jinf.2012.01.001","article-title":"Stenotrophomonas maltophilia\u2013the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study","volume":"64","author":"Fihman","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2022.06.003_bib0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/IDR.S240963","article-title":"Molecular characteristics and antimicrobial susceptibility profiles of Elizabethkingia clinical isolates in Shanghai","volume":"13","author":"Wang","year":"2020","journal-title":"China. Infect Drug Resist"},{"key":"10.1016\/j.jgar.2022.06.003_bib0008","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M07, 11th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018."},{"key":"10.1016\/j.jgar.2022.06.003_bib0009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jac\/45.6.921","article-title":"Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics","volume":"45","author":"Schmitz","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.06.003_bib0010","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1128\/JCM.38.10.3636-3645.2000","article-title":"Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping","volume":"38","author":"Brisse","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2022.06.003_bib0011","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/phar.2447","article-title":"An overview of the treatment of less common non-lactose-fermenting Gram-negative bacteria","volume":"40","author":"Spencer","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2022.06.003_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0034-1396929","article-title":"Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies","volume":"36","author":"Abbott","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2022.06.003_bib0013","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/clinids\/4.2.429","article-title":"Adverse reactions to trimethoprim-sulfamethoxazole","volume":"4","author":"Lawson","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jgar.2022.06.003_bib0014","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/0049825011","article-title":"Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects","volume":"31","author":"O'Grady","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jgar.2022.06.003_bib0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10156-013-0580-2","article-title":"Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections","volume":"19","author":"Tanigawara","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2022.06.003_bib0016","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jgar.2020.06.001","article-title":"Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis","volume":"22","author":"Damar-\u00c7elik","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.06.003_bib0017","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/mdr.2011.0195","article-title":"In vitro antimicrobial activity of \u2018last-resort\u2019 antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates","volume":"18","author":"Jacquier","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2022.06.003_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijantimicag.2018.09.001","article-title":"Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients","volume":"53","author":"D\u00edez-Aguilar","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.06.003_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/microorganisms7090295","article-title":"Elizabethkingia infections in humans: from genomics to clinics","volume":"7","author":"Lin","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2022.06.003_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijantimicag.2017.05.018","article-title":"Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia","volume":"51","author":"Huang","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.06.003_bib0021","doi-asserted-by":"crossref","first-page":"668","DOI":"10.21037\/atm-21-933","article-title":"Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai","volume":"9","author":"Zhang","year":"2021","journal-title":"China. Ann Transl Med"},{"key":"10.1016\/j.jgar.2022.06.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02256-18","article-title":"Differences in clinical manifestations, antimicrobial susceptibility patterns, and mutations of fluoroquinolone target genes between Chryseobacterium gleum and Chryseobacterium indologenes","volume":"63","author":"Lin","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:23:21Z","timestamp":1778858601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"alternative-id":["S2213716522001369"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.06.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}